The Journal of Pediatrics
Volume 151, Issue 6 , Pages 571-574 , December 2007

Effect of 1-Desamino-8-D-Arginine Vasopressin on Prepulse Inhibition of Startle Supports a Central Etiology of Primary Monosymptomatic Enuresis

Received 16 November 2006 ,Revised 28 March 2007 ,Accepted 7 May 2007.

References 

  1. Van Kampen M, Bogaert G, Akinwuntan EA, Claessen L, Van Poppel H, De Weerdt W. Long-term efficacy and predictive factors of full-spectrum therapy for nocturnal enuresis. J Urol. 2004;171:2599–2602
  2. Glazener CM, Evans JH. Alarm interventions for nocturnal enuresis in children. Nurs Times. 2001;97:37
  3. Chiozza ML, del Gado R, di Toro R, Ferrara P, Fois A, Giorgi P, et al. Italian multicentre open trial on dDAVP spray in nocturnal enuresis. Scand J Urol Nephrol. 1999;33:42–48
  4. Gepertz S, Neveus T. Imipramine for therapy-resistant enuresis: a retrospective evaluation. J Urol. 2004;171:2607–2610
  5. Moffatt ME, Harlos S, Kirshen AJ, Burd L. Desmopressin acetate and nocturnal enuresis: how much do we know?. Pediatrics. 1993;92:420–425
  6. Neveus T, Lackgren G, Tuvemo T, Hetta J, Hjalmas K, Stenberg A. Enuresis: background and treatment. Scand J Urol Nephrol Suppl. 2000;1–44
  7. Ornitz EM, Hanna GL, de Traversay J. Prestimulation-induced startle modulation in attention-deficit hyperactivity disorder and nocturnal enuresis. Psychophysiology. 1992;29:437–451
  8. Ornitz EM, Russell AT, Hanna GL, Gabikian P, Gehricke JG, Song D, et al. Prepulse inhibition of startle and the neurobiology of primary nocturnal enuresis. Biol Psychiatry. 1999;45:1455–1466
  9. Neveus T, von Gontard A, Hoebeke P, Hjalmas K, Bauer S, Bower W, et al. The standardization of terminology of lower urinary tract function in children and adolescents: Report from the standardization committee of the International Children’s Continence Society (ICCS). Neurourol Urodyn. 2007;26:90–102
  10. Iwasaki H, Koyama Y, Tanaka Y, Kawauchi A, Jodo E, Kayama Y, et al. Modulation by desmopressin of neuronal activity in the brainstem micturition center. Urology. 2004;63:994–998
  11. Gouzenes L, Sabatier N, Richard P, Moos FC, Dayanithi G. V1a- and V2-type vasopressin receptors mediate vasopressin-induced Ca2+ responses in isolated rat supraoptic neurones. J Physiol. 1999;517:771–779
  12. Arnauld E, Bibene V, Meynard J, Rodriguez F, Vincent J. Effect of chronic icv infusion of vasopressin on sleep-waking cycle of rats. Am J Physiol. 1989;256:674–684
  13. DiMichele S, Sillen U, Engel JA, Hjalmas K, Rubenson A, Soderpalm B. Desmopressin and vasopressin increase locomotor activity in the rat via a central mechanism: implications for nocturnal enuresis. J Urol. 1996;156:1164–1168
  14. Fehm-Wolfsdorf G, Born J, Voigt KH, Fehm HL. Behavioral effects of vasopressin. Neuropsychobiology. 1984;11:49–53
  15. Gais S, Sommer M, Fischer S, Perras B, Born J. Post-trial administration of vasopressin in humans does not enhance memory formation (vasopressin and memory consolidation). Peptides. 2002;23:581–583
  16. Lolait SJ, O’Carroll AM, Mahan LC, Felder CC, Button DC, Young WS, et al. Extrapituitary expression of the rat V1b vasopressin receptor gene. Proc Natl Acad Sci U S A. 1995;92:6783–6787
  17. Valentino RJ, Page ME, Luppi PH, Zhu Y, Van Bockstaele E, Aston-Jones G. Evidence for widespread afferents to Barrington’s nucleus, a brainstem region rich in corticotropin-releasing hormone neurons. Neuroscience. 1994;62:125–143
  18. Trousseau A. Incontinence nocturne de l’urine. Librairies de l’Académie Royale de Médecine. 1868;2:719–732

 The authors have no financial or other conflicts of interest to declare. There was no external funding source; the study was supported by research funds from their university.

PII: S0022-3476(07)00489-1

doi: 10.1016/j.jpeds.2007.05.024

The Journal of Pediatrics
Volume 151, Issue 6 , Pages 571-574 , December 2007

Article Tools

* Image Usage & Resolution